MCL1 and pancreatic neoplasm: Several compounds, notably 18, 20, 21, 23, and 24, displayed activity towards the pancreatic cancer cell lines BxPC‐3, known to overexpress Mcl‐1, and MiaPaCa‐2, which overexpresses both Mcl‐1 and Bcl‐2.